Microstructural Tissue Changes in Alzheimer Disease Brains: Insights from Magnetization Transfer Imaging.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
04 2021
Historique:
received: 01 07 2020
accepted: 23 10 2020
pubmed: 30 1 2021
medline: 13 10 2021
entrez: 29 1 2021
Statut: ppublish

Résumé

Reductions in magnetization transfer ratio have been associated with brain microstructural damage. We aim to compare magnetization transfer ratio in global and regional GM and WM between individuals with Alzheimer disease and healthy control participants to analyze the relationship between magnetization transfer ratio and cognitive functioning in Alzheimer disease. In this prospective study, participants with Alzheimer disease and a group of age-matched healthy control participants underwent clinical examinations and 3T MR imaging. Magnetization transfer ratios were determined in the cortex, AD-signature regions, normal-appearing WM, and WM hyperintensities. Seventy-seven study participants (mean age ± SD, 72 ± 8 years; 47 female) and 77 age-matched healthy control participants (mean age ± SD, 72 ± 8 years; 44 female) were evaluated. Magnetization transfer ratio values were lower in patients with Alzheimer disease than in healthy control participants in all investigated regions. When adjusting for atrophy and extent of WM hyperintensities, significant differences were seen in the global cortex (OR = 0.47; 95% CI: 0.22, 0.97; Alzheimer disease is associated with magnetization transfer ratio reductions in GM and WM regions of the brain. Lower magnetization transfer ratios in the entire cortex and AD-signature regions contribute to cognitive impairment independent of brain atrophy and WM damage.

Sections du résumé

BACKGROUND AND PURPOSE
Reductions in magnetization transfer ratio have been associated with brain microstructural damage. We aim to compare magnetization transfer ratio in global and regional GM and WM between individuals with Alzheimer disease and healthy control participants to analyze the relationship between magnetization transfer ratio and cognitive functioning in Alzheimer disease.
MATERIALS AND METHODS
In this prospective study, participants with Alzheimer disease and a group of age-matched healthy control participants underwent clinical examinations and 3T MR imaging. Magnetization transfer ratios were determined in the cortex, AD-signature regions, normal-appearing WM, and WM hyperintensities.
RESULTS
Seventy-seven study participants (mean age ± SD, 72 ± 8 years; 47 female) and 77 age-matched healthy control participants (mean age ± SD, 72 ± 8 years; 44 female) were evaluated. Magnetization transfer ratio values were lower in patients with Alzheimer disease than in healthy control participants in all investigated regions. When adjusting for atrophy and extent of WM hyperintensities, significant differences were seen in the global cortex (OR = 0.47; 95% CI: 0.22, 0.97;
CONCLUSIONS
Alzheimer disease is associated with magnetization transfer ratio reductions in GM and WM regions of the brain. Lower magnetization transfer ratios in the entire cortex and AD-signature regions contribute to cognitive impairment independent of brain atrophy and WM damage.

Identifiants

pubmed: 33509922
pii: ajnr.A6975
doi: 10.3174/ajnr.A6975
pmc: PMC8040982
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

688-693

Subventions

Organisme : Austrian Science Fund FWF
ID : I 2889
Pays : Austria

Informations de copyright

© 2021 by American Journal of Neuroradiology.

Auteurs

I Colonna (I)

From the Department of Neurology (I.C., M.K., L.P., A.D., P.S., C.E., R.S., S.R.).

M Koini (M)

From the Department of Neurology (I.C., M.K., L.P., A.D., P.S., C.E., R.S., S.R.).

L Pirpamer (L)

From the Department of Neurology (I.C., M.K., L.P., A.D., P.S., C.E., R.S., S.R.).

A Damulina (A)

From the Department of Neurology (I.C., M.K., L.P., A.D., P.S., C.E., R.S., S.R.).

E Hofer (E)

Institute for Medical Informatics, Statistics and Documentation (E.H.).

P Schwingenschuh (P)

From the Department of Neurology (I.C., M.K., L.P., A.D., P.S., C.E., R.S., S.R.).

C Enzinger (C)

From the Department of Neurology (I.C., M.K., L.P., A.D., P.S., C.E., R.S., S.R.).
Division of Neuroradiology, Vascular & Interventional Radiology, Department of Radiology (C.E.), Medical University of Graz, Graz, Austria.

R Schmidt (R)

From the Department of Neurology (I.C., M.K., L.P., A.D., P.S., C.E., R.S., S.R.) reinhold.schmidt@medunigraz.at.

S Ropele (S)

From the Department of Neurology (I.C., M.K., L.P., A.D., P.S., C.E., R.S., S.R.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH